Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

Centers With Higher Volume of Peripheral Endovascular Procedures Have Better Results

Todd Neale

July 02, 2015

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

Advertisement

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Centers With Higher Volume of Peripheral Endovascular Procedures Have Better Results

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content